PFIZER INC — Director's Dealing 2019

Mar 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2019-02-27

Reporting Person: Dolsten Mikael (President R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-27	Common Stock	A	96183.0000	$0.0000	Acquired	406261.0000	Direct
2019-02-27	Common Stock	F	26672.0000	$42.9300	Disposed	379589.0000	Direct
2019-02-27	Common Stock	F	47101.0000	$42.9300	Disposed	332488.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-28	Stock Appreciation Rights	$43.3500	A	150419.0000	Acquired	2024-02-28	Common Stock (150419.0000)	Direct
2019-02-28	Stock Appreciation Rights	$43.3500	A	126762.0000	Acquired	2026-02-28	Common Stock (126762.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1625.0000	Indirect

Footnotes

F1: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).

F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).

F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).

F4: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F5: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.